- Benchmark ASINB084YY2KXB
- MarketplaceUK
- Category ID65801031
- Analyzed Products
- Keywordcollagen capsules, multi collagen, collagen supplement
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-24
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，已经是明显的价格战区，而且新品牌持续涌入但大多数都做不成。 现在可见的新品牌有12个，新增产品30个里只有3个真正盈利，成功率10.00%到12.50%，远低于可接受线；利润分布也很差，新上架产品利润率范围只有-3.16%到12.83%，绝大多数都卡在10%以下，说明这里不是“有点难”，而是已经在拼低价和拼投放，用户不该进场。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很直接：这个市场不值得进入。 新品盈利率只有10%，整体可盈利产品也只有15.79%，而且新品牌里已经出现多家“看起来在卖、实际上不赚钱”的情况，说明这里更像是价格战市场，不是适合新手或中小品牌的机会场。
Early sourcing + logistics + marketing budget (GBP)£487.56 - £487.56Explains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?46.66%New listing success rate (old brands):7.14%New listing success rate (new brands):12.50%Which new brands have these successful new listings?Which old brands have these successful new listings?Alternatives- 胶原蛋白口服液/液体shot：通常比胶囊更容易吞咽，适合不想每天吞多粒胶囊的人；在亚马逊英国上也常见到低门槛小包装，单次试用成本较低。
- 维生素C补充剂：如果用户购买胶原蛋白的核心诉求是‘促进自身胶原合成’，维C是更便宜、更基础、获取更容易的替代方案，且剂型多、价格通常低于多胶原复配。
- 透明质酸胶囊/口服保湿类补充剂：对偏重皮肤保湿、干燥感管理的用户，这是比多胶原更聚焦的替代；配方更简单，通常也更容易找到入门价位产品。
- 生物素单方或头发皮肤指甲复合维生素：如果购买胶原蛋白的动机主要是头发、皮肤、指甲保养，这类复合维生素往往更便宜、选择更多、服用更简单。
- 高蛋白即饮奶昔/蛋白粉：对于想从‘补蛋白’间接支持皮肤和整体营养的人，蛋白粉通常单次成本更低、补充效率更高，也更容易按日常饮食习惯使用。
- 明胶食品或食用明胶粉：若用户主要想要‘胶原来源/动物蛋白’概念，而不是精准营养配方，明胶粉或相关食品往往更便宜、购买更方便，适合低成本试水。
- 骨汤/骨髓汤类即食产品：对把胶原蛋白视为饮食型补充的人，这类产品更接近日常食物，使用门槛低，也常比专门胶原胶囊更容易获得。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入：已出现明显价格战和超饱和信号，新品牌成功率只有10.00%，整体可盈利产品仅15.79%，而且近一年新品牌持续涌入但大多数都在亏。 对大品牌和小品牌来说都不是好市场；小品牌若硬进，基本只能靠极强的差异化和激进投放，但从现有数据看，胜算很低。
New products with Highest revenueNutrian
Recent Monthly Revenue (GBP):-(-)B0GWFR2281Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (GBP):£734.00(50pcs/month)B0FZ3TS18N (4.5/5 (39 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (GBP):£6,291.00(900pcs/month)B0FL87PXF1 (4.5/5 (165 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatNet profit margin below 10.00%Old brand with the most profitable new productsRevive Naturals
Recent Monthly Revenue (GBP):£29,560.00(2000pcs/month)B084YY2KXB (4.5/5 (569 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitable
Recent Monthly Revenue (GBP):£19,980.00(2000pcs/month)B084QJ5QL2 (4.4/5 (1806 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitable
Recent Monthly Revenue (GBP):£4,995.00(500pcs/month)B0CD5YGLYN (4.4/5 (734 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableMost investment in new productsLeast investment in new productsSealiit
Recent Monthly Revenue (GBP):-(-)B0GPNS9BLS (4.4/5 (29 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (GBP):£433.00(50pcs/month)B0GND3NR9K (4.2/5 (29 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatNet profit margin below 10.00%Least profitable new productsAMBROSIAL
Recent Monthly Revenue (GBP):-(-)B0FLYCMQB6 (4.8/5 (14 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 粉色补充袋外观，与常见白/蓝/黑瓶装差异大，货架辨识度高
- |
- 胶囊剂型，满足不想冲粉、追求方便的人群
- |
- 胶原蛋白+透明质酸+维生素C+生物素，兼顾美容与关节需求
- |
- 更偏女性美容营养场景，图片风格更像护肤补充品，容易吸引点击
B0FZVLZ8HW (4.8/5 (62 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 海洋胶原+南非醉茄的组合较少见，功能差异明显
- |
- 120粒大包装、3粒/日，视觉上与常见月装不同
- |
- 强调肌肤、睡眠、疲劳管理，目标人群更细分
- |
- 和其他主流胶原产品相比，配方路线更独特，容易在列表中被注意到
B0CP2CGBXP (4.4/5 (208 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseNet profit margin below 10.00%Sales & BSR
#Net Profit Margins: All vs New
Listing这不是一个适合进入的市场：新品牌成功率只有10%，而新上架产品里亏损或低于10%利润的占绝大多数，已经是明显的价格战/饱和区。 500000 CNY 的预算看起来够用，但在这个市场里并不能换来稳定胜率，因为真正跑出来的不是普通小商家，而是少数靠品牌力、投放力或较强产品力硬推出来的玩家。
Profitability difficultyHigh Risk Due to Price CompetitionAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B084YQW9DNALPHA012018-10-21Yes£9.993000pcs£29970.010.46%£3134.87B084YY2KXBRevive Naturals2018-10-21Yes£14.782000pcs£29560.010.44%£3086.07B084QJ5QL2Revive Naturals2018-10-21Yes£9.992000pcs£19980.010.08%£2013.99B0FZVLZ8HWYOU WELLNESS2025-11-10Yes£14.35300pcs£4305.018.54%£798.15
B0CD5ZJQW4Revive Naturals2023-07-30Yes£15.99300pcs£4797.011.41%£547.34B0CD5YGLYNRevive Naturals2023-07-30Yes£9.99500pcs£4995.010.32%£515.49
B0DSFY9BQXEdible Health2025-01-07Yes£14.51300pcs£4353.011.36%£494.51
B086DT75XWXspan Labs2020-03-26Yes£13.97100pcs£1397.018.4%£257.05
B088KRR8VYALPHA012020-06-09Yes£14.99100pcs£1499.010.65%£159.65
B0CH3YQV5YONYX INGREDIENTS 1012021-06-07Yes£18.1150pcs£905.514.12%£127.86B0FZXP1RBNMoovWell2025-11-05Yes£13.2750pcs£663.516.96%£112.53
B07Y5FD69Mswiss bioenergetics2019-09-18Yes£12.9750pcs£648.515.76%£102.21
B0FMCBXZDHSkinPep2025-08-22Yes£10.5350pcs£526.513.32%£70.13
B01KLW3BVQswiss bioenergetics2016-08-15Yes£9.9750pcs£498.512.54%£62.52
B001M4YEUKTroo Health Care2011-12-22Yes£8.9750pcs£448.510.43%£46.78Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0FZVLZ8HWYOU WELLNESS2025-11-10Yes£14.35300pcs£4305.018.54%£798.15B0FZXP1RBNMoovWell2025-11-05Yes£13.2750pcs£663.516.96%£112.53B0FMCBXZDHSkinPep2025-08-22Yes£10.5350pcs£526.513.32%£70.13#New Product Success Rates
Listing这个市场不值得进入，已经接近或处于过度拥挤状态，且利润战非常明显。整体新产品成功率只有10.00%，而新品牌只有12.50%能做成，旧品牌也只有8.33%，说明多数新品都在失败；再看利润分布，市场里低于10%利润率的产品占绝对多数，典型就是价格战市场，进场风险很高。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
YOU WELLNESSMoovWellSkinPepNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
NutrianNutravitaOther#Success Rate by Entry Time
Listing结论很明确：这个市场不可进入，已经进入高风险价格战区，不适合大品牌也不适合小品牌。 近期新品牌成功率只有10.00%，而新品牌新品里真正盈利的只有12.50%，同时2025年后新品牌进入明显增多，但新增项目里大多数都亏损，说明竞争正在加剧而不是变得更容易。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 3 2 3 0 0 0 8 2026 0 0 1 0 0 0 0 13 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 1 1 0 0 0 0 0 2025/8 0 0 1 1 0 0 0 4 2025/9 0 0 0 0 0 0 0 0 2025/10 0 2 0 0 0 0 0 0 2025/11 0 0 0 2 0 0 0 2 2025/12 0 0 0 0 0 0 0 2 2026/1 0 0 0 0 0 0 0 2 2026/2 0 0 1 0 0 0 0 2 2026/3 0 0 0 0 0 0 0 3 2026/4 0 0 0 0 0 0 0 2 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesMarine Collagen Capsules 2400mg - Wild Caught with Hyaluronic Acid & Vitamin C - 180 Capsules (Not Collagen Powder/Collagen Tablets) - Collagen Complex for Skin Joints & Hair for Women & Men
This listing is deemed profitablePrice (GBP)£14.99Released TypeOld Release (2020-06-09)Brand is an old entry in this marketSize and Weight20.1 x 12.6 x 3.7 cm, 124.00gProfitable Factors
Based on old ASINDistinct functions and featuresDesign & Appearance
黑色软袋包装搭配青绿色竖向标识，整体更偏成熟保健品风格。, 180粒大容量胶囊装，适合长期复购场景；与常见60/90粒竞品相比更偏高容量随身补充方案。Key Buying Motive
主打海洋胶原蛋白＋透明质酸＋维生素C的基础复配，且明确区分为胶囊而非粉剂/片剂。Target Customers
更适合偏好大包装、方便吞服、且不想用粉末冲调的英区日常美容营养补充人群。Early Investment
Investment
Monthly Revenue (Recent) (GBP)£1,499.00100 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight10.37% / 10.65%Peak / Non PeakRail Freight6.10% / 6.39%Peak / Non PeakAir Freight6.10% / 6.39%Peak / Non PeakSales & BSR Performance
Marine Collagen Peptides - SkinPep | 60 Capsules, 1300mg Per Serving | WildCaught Bioactive 1000 Daltons | Hyaluronic Acid | VIT C | Clean & Pure, No Fillers | Collagen Supplements for Women and Men
This listing is deemed profitablePrice (GBP)£10.53Released TypeNew Release (2025-08-22)Brand is an old entry in this marketSize and Weight22.6 x 13.0 x 1.3 cm, 50.00gProfitable Factors
Based on old ASINDistinct functions and featuresDesign & Appearance
粉金色配色，整体更偏女性化和美容感, 60粒胶囊的小包装，强调便携和一个月用量Key Buying Motive
主打海洋胶原蛋白肽 + 透明质酸 + 维生素C + 生物素的组合，并强调1000 Dalton小分子吸收Target Customers
更偏向想用胶囊形式补充美容型胶原、且不喜欢粉剂或鱼腥味的人群Early Investment
Investment
Monthly Revenue (Recent) (GBP)£526.5050 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight13.15% / 13.32%Peak / Non PeakRail Freight10.68% / 10.84%Peak / Non PeakAir Freight10.68% / 10.84%Peak / Non PeakSales & BSR Performance
Loading samples... 50%